Quarterly report · Q2
2150.TEDINET S100ROY9
Period2023-01-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥5.0bn | 2023-01-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥9.3bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.3bn | 2022-01-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | ¥1.3bn | 2023-01-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥1.5bn | 2022-01-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥1.3bn | 2023-01-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.9bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.5bn | 2022-01-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.4bn | 2023-01-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.5bn | 2022-01-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥860m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.8bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥998m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥865m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥1.0bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥12.9bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥13.1bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥10.7bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.3bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥3.1bn | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥10.6bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥10.0bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥8.8bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥8.6bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥7.8bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥8.4bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.7bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.5bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.2bn | at 2021-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.1bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.8bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥629m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥86m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.1bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥76m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥285m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥260m | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥258m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥19.29 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥9.02 | 2023-04-01 → 2023-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥41.7 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.55 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥9.94 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 82.0% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.4% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 82.1% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 8
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | −¥764m |
| —segment total | revenue | 2023-01-01 → 2023-06-30 | ¥5.0bn |
| —segment total | revenue external | 2023-01-01 → 2023-06-30 | ¥5.0bn |
| —segment total | segment profit | 2023-01-01 → 2023-06-30 | ¥2.1bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-06-30 | −¥613m |
| —segment total | revenue | 2022-01-01 → 2022-06-30 | ¥4.3bn |
| —segment total | revenue external | 2022-01-01 → 2022-06-30 | ¥4.3bn |
| —segment total | segment profit | 2022-01-01 → 2022-06-30 | ¥2.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 511
| Item | Context | Value | Unit |
|---|---|---|---|
| Retirement benefit expenses sga | CurrentYTDDuration | 324000 | JPY |
| Provision for directors retirement benefits sga | Prior1YTDDuration | － | JPY |
| Provision for directors retirement benefits sga | CurrentYTDDuration | 2250000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YTDDuration | － | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYTDDuration | 1945000 | JPY |
| Provision for point card certificates sga | Prior1YTDDuration | 42537000 | JPY |
| Provision for point card certificates sga | CurrentYTDDuration | 24536000 | JPY |
| Provision for share based remuneration for directors and other officers sga | Prior1YTDDuration | 10836000 | JPY |
| Provision for share based remuneration for directors and other officers sga | CurrentYTDDuration | 10836000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E05684-000MedicalDigitalTransformationBusinessMember | 3829365000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E05684-000MedicalPlatformBusinessMember | 444992000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 4274358000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 4274358000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E05684-000MedicalDigitalTransformationBusinessMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E05684-000MedicalPlatformBusinessMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E05684-000MedicalDigitalTransformationBusinessMember | 3829365000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E05684-000MedicalPlatformBusinessMember | 444992000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 4274358000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1YTDDuration | 4274358000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E05684-000MedicalDigitalTransformationBusinessMember | 1937405000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E05684-000MedicalPlatformBusinessMember | 175619000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 2113025000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -612950000 | JPY |
| Operating income | Prior1YTDDuration | 1500074000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E05684-000MedicalDigitalTransformationBusinessMember | 4425379000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E05684-000MedicalPlatformBusinessMember | 588719000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 5014099000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 5014099000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E05684-000MedicalDigitalTransformationBusinessMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E05684-000MedicalPlatformBusinessMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E05684-000MedicalDigitalTransformationBusinessMember | 4425379000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E05684-000MedicalPlatformBusinessMember | 588719000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 5014099000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | CurrentYTDDuration | 5014099000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E05684-000MedicalDigitalTransformationBusinessMember | 1848542000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E05684-000MedicalPlatformBusinessMember | 234272000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 2082814000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -764026000 | JPY |
| Operating income | CurrentYTDDuration | 1318788000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |